Across the recent three months, 11 analysts have shared their insights on 3M MMM, expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 6 | 1 | 2 | 0 |
| Last 30D | 1 | 3 | 1 | 1 | 0 |
| 1M Ago | 0 | 2 | 0 | 1 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
Analysts have set 12-month price targets for 3M, revealing an average target of $153.73, a high estimate of $184.00, and a low estimate of $96.00. Observing a 6.96% increase, the current average has risen from the previous average price target of $143.73.
Exploring Analyst Ratings: An In-Depth Overview
The standing of 3M among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Deane Dray | RBC Capital | Maintains | Underperform | $96.00 | $96.00 |
| Andrew Obin | B of A Securities | Raises | Buy | $175.00 | $160.00 |
| Andrew Kaplowitz | Citigroup | Raises | Neutral | $152.00 | $142.00 |
| Julian Mitchell | Barclays | Raises | Overweight | $165.00 | $161.00 |
| Stephen Tusa | JP Morgan | Raises | Overweight | $165.00 | $162.00 |
| Joe O'Dea | Wells Fargo | Raises | Overweight | $170.00 | $140.00 |
| Stephen Tusa | JP Morgan | Lowers | Overweight | $162.00 | $165.00 |
| Julian Mitchell | Barclays | Lowers | Overweight | $161.00 | $165.00 |
| Matthew Swanson | RBC Capital | Lowers | Underperform | $96.00 | $100.00 |
| Damian Karas | UBS | Raises | Buy | $184.00 | $130.00 |
| Stephen Tusa | JP Morgan | Raises | Overweight | $165.00 | $160.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to 3M. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of 3M compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of 3M's stock. This examination reveals shifts in analysts' expectations over time.
To gain a panoramic view of 3M's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on 3M analyst ratings.
Discovering 3M: A Closer Look
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
3M's Financial Performance
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Positive Revenue Trend: Examining 3M's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.38% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: 3M's net margin excels beyond industry benchmarks, reaching 21.8%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): 3M's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 32.06% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.26%, the company showcases effective utilization of assets.
Debt Management: 3M's debt-to-equity ratio is below the industry average at 2.97, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst Ratings: Simplified
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
